Does NEPAFENAC Cause Corneal epithelium defect? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Corneal epithelium defect have been filed in association with NEPAFENAC (ILEVRO). This represents 0.6% of all adverse event reports for NEPAFENAC.
11
Reports of Corneal epithelium defect with NEPAFENAC
0.6%
of all NEPAFENAC reports
1
Deaths
0
Hospitalizations
How Dangerous Is Corneal epithelium defect From NEPAFENAC?
Of the 11 reports, 1 (9.1%) resulted in death.
Is Corneal epithelium defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEPAFENAC. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NEPAFENAC Cause?
Eye pain (393)
Drug ineffective (270)
Treatment failure (208)
Vision blurred (133)
Eye irritation (67)
Visual impairment (66)
Product quality issue (57)
Liquid product physical issue (55)
Off label use (43)
Cystoid macular oedema (42)
What Other Drugs Cause Corneal epithelium defect?
MOXIFLOXACIN (43)
PREDNISOLONE (37)
DEVICE (32)
BELANTAMAB MAFODOTIN (31)
RIBOFLAVIN 5'-PHOSPHATE (29)
DICLOFENAC (23)
METHOTREXATE (23)
PROPARACAINE (23)
BEVACIZUMAB (22)
CYCLOPENTOLATE (20)
Which NEPAFENAC Alternatives Have Lower Corneal epithelium defect Risk?
NEPAFENAC vs NERATINIB
NEPAFENAC vs NETARSUDIL
NEPAFENAC vs NETUPITANT\PALONOSETRON
NEPAFENAC vs NEULASTA
NEPAFENAC vs NEUPOGEN